The n-Lorem Foundation and EspeRare Foundation have entered a strategic partnership aimed at expanding access to personalized ASO therapies for rare genetic diseases in Europe. This collaboration will first target nano-rare patients in Switzerland while developing scalable models for broader access across the EU.
Company Information
Company
n-Lorem Foundation
Location
Cambridge, Massachusetts, United States
About
n-Lorem Foundation is a non-profit organization established to apply the efficiency, versatility and specificity of antisense technology to charitably provide experimental antisense oligonucleotide (ASO) medicines for treating nano-rare patients. These patients are diagnosed with diseases resulting from a single genetic defect unique to only a small number of individuals. By developing individualized ASO medicines, n-Lorem aims to provide treatment options where few exist. The foundation seeks to bring hope to those in the nano-rare community who have historically been overlooked by the healthcare system.
CambridgeBiotechnologyHealth CareMedicalTherapeuticsNon Profit